4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Alebund Pharmaceuticals (Jiangsu) Limited (9637) operates in the Drug Manufacturers - General industry and is headquartered in Yangzhou, China with about 169 employees. Its market capitalization is roughly HK$9 billion. In the fiscal year ended 2025-12-31, 9637 reported CNY 31M in revenue and (CNY 750M) in net income.
Alebund Pharmaceuticals (Jiangsu) Limited operates as a biopharmaceutical company that develops therapies for kidney diseases and their complications in China and Hong Kong.
Interactive charts & full statements → Open the 9637 valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Total Revenue | CNY 31M | CNY 6M |
| Gross Profit | CNY 13M | CNY 2M |
| Operating Income (EBIT) | (CNY 641M) | (CNY 307M) |
| Net Income | (CNY 750M) | (CNY 326M) |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Total Assets | CNY 1.3B | CNY 1.1B |
| Total Liabilities | CNY 837M | CNY 2.5B |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 9637 viewer.
About TickerBase · Data methodology & sources · Privacy · Terms